{"id":5469,"date":"2025-02-06T13:30:14","date_gmt":"2025-02-06T13:30:14","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=5469"},"modified":"2025-05-06T07:25:56","modified_gmt":"2025-05-06T07:25:56","slug":"neusignal-therapeutics-raises-22-5-million-in-series-a-funding","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/","title":{"rendered":"\u30cb\u30e5\u30fc\u30b7\u30b0\u30ca\u30eb\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u304c\u30b7\u30ea\u30fc\u30baA\u8cc7\u91d1\u8abf\u9054\u3067$2250\u4e07\u30c9\u30eb\u3092\u8abf\u9054"},"content":{"rendered":"<p><a href=\"https:\/\/neusignal-tx.com\/\">\u30cb\u30e5\u30fc\u30b7\u30b0\u30ca\u30eb\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>\u6771\u5317\u5927\u5b66\u767a\u306e\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\u6cbb\u7642\u85ac\u958b\u767a\u4f01\u696d\u3067\u3042\u308b\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u4e0b\u8a18\u306e\u51fa\u8cc7\u8005\u3092\u5f15\u53d7\u5148\u3068\u3059\u308b\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u3092\u5b9f\u65bd\u3057\u3001\u30b7\u30ea\u30fc\u30baA\u306711.5\u5104\u5186\u306e\u8cc7\u91d1\u8abf\u9054\u3092\u884c\u3044\u307e\u3057\u305f\uff1a\u307e\u305f\u3001AMED\u306e2023\u5e74\u5ea6\u300c\u5275\u85ac\u30d9\u30f3\u30c1\u30e3\u30fc\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u5f37\u5316\u4e8b\u696d\u300d\u306b\u3088\u308b\u9769\u65b0\u7684\u5275\u85ac\u958b\u767a\u306b\u53d6\u308a\u7d44\u3080\u30d9\u30f3\u30c1\u30e3\u30fc\u4f01\u696d\u306e\u6210\u9577\u652f\u63f4\u3068\u3057\u306611\u5104\u5186\u306e\u52a9\u6210\u3092\u53d7\u3051\u3001\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u984d\u306f22.5\u5104\u5186\u3068\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n<h4><strong>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/juntendo-university-and-ibm-japan-begin-working-on-building-and-operating-a-pfm-ai-matching-system-to-help-patients-transfer-to-the-most-suitable-medical-institution\/\" rel=\"bookmark\">\u9806\u5929\u5802\u5927\u5b66\u3068\u65e5\u672cIBM\u3001\u60a3\u8005\u306e\u6700\u9069\u306a\u533b\u7642\u6a5f\u95a2\u3078\u306e\u8ee2\u9662\u3092\u652f\u63f4\u3059\u308bPFM AI\u30de\u30c3\u30c1\u30f3\u30b0\u30b7\u30b9\u30c6\u30e0\u306e\u69cb\u7bc9\u30fb\u904b\u7528\u306b\u7740\u624b<\/a><\/strong><\/h4>\n<h3><strong>\u80cc\u666f<\/strong><\/h3>\n<p>NTX\u306f\u6771\u5317\u5927\u5b66\u767a\u30b7\u30fc\u30ba\u306e\u4e8b\u696d\u5316\u306b\u53d6\u308a\u7d44\u3080\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3067\u3059\u3002\u4e16\u754c\u4e2d\u3067\u6025\u5897\u3057\u3066\u3044\u308b\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306e\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u901a\u3058\u3066\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306b\u82e6\u3057\u3080\u60a3\u8005\u3055\u3093\u3084\u305d\u306e\u3054\u5bb6\u65cf\u306e\u751f\u6d3b\u5411\u4e0a\u306b\u8ca2\u732e\u3059\u3079\u304f\u3001\u533b\u85ac\u54c1\u5019\u88dc\u5316\u5408\u7269\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002<\/p>\n<p>\u8fd1\u5e74\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u578b\u8a8d\u77e5\u75c7\u306e\u9032\u884c\u3092\u9045\u3089\u305b\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u308b\u65b0\u85ac\u304c\u767b\u5834\u3057\u3001\u671f\u5f85\u304c\u9ad8\u307e\u308b\u4e00\u65b9\u3067\u3001\u6cbb\u7642\u7ba1\u7406\u306e\u96e3\u3057\u3055\u3001\u9ad8\u984d\u306a\u533b\u7642\u8cbb\u3001\u30ea\u30b9\u30af\u30fb\u30ea\u30bf\u30fc\u30f3\u306b\u57fa\u3065\u304f\u5bfe\u8c61\u60a3\u8005\u306e\u59a5\u5f53\u6027\u7b49\u3001\u69d8\u3005\u306a\u8b70\u8ad6\u304c\u306a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5f53\u793e\u306e\u958b\u767a\u54c1\u306f\u3001\u3053\u308c\u3089\u306e\u8ab2\u984c\u3092\u89e3\u6c7a\u3059\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u85ac\u306b\u306a\u308b\u3068\u78ba\u4fe1\u3057\u3066\u304a\u308a\u3001\u5f85\u3061\u671b\u3093\u3067\u3044\u308b\u60a3\u8005\u3055\u3093\u3084\u3054\u5bb6\u65cf\u306b\u304a\u5c4a\u3051\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/prtimes.jp\/main\/html\/rd\/p\/000000003.000138577.html\">PR\u30bf\u30a4\u30e0\u30ba<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Neusignal Therapeutics Inc., a Tohoku University-based company developing treatments for Alzheimer&#8217;s disease, has raised 1.15 billion yen in Series A funding through a third-party allotment of new shares to the following investors: In addition, the company has received a 1.1 billion yen subsidy from AMED&#8217;s FY2023 &#8220;Drug Discovery Venture Ecosystem Strengthening Project&#8221; to support the growth of venture companies engaged in innovative drug discovery development, bringing the total amount raised in this round to 2.25 billion yen. Also Read: Juntendo University and IBM Japan begin working on building and operating a PFM AI matching system to help patients transfer to the most suitable medical institution Background NTX is a startup [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5470,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,211,237,206],"tags":[872,150,493,874,871,873],"ppma_author":[205],"class_list":{"0":"post-5469","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-japan","10":"category-news","11":"category-regional","12":"tag-alzheimer-disease","13":"tag-biotech","14":"tag-investments","15":"tag-neusignal-therapeutics","16":"tag-ntx","17":"tag-series-a-funding"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neusignal Therapeutics Raises $22.5M in Series A<\/title>\n<meta name=\"description\" content=\"Neusignal Therapeutics has raised 1.15 billion yen in Series A funding through a third-party allotment of new shares.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neusignal Therapeutics Raises $22.5M in Series A\" \/>\n<meta property=\"og:description\" content=\"Neusignal Therapeutics has raised 1.15 billion yen in Series A funding through a third-party allotment of new shares.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T13:30:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-06T07:25:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neusignal Therapeutics\u304c\u30b7\u30ea\u30fc\u30baA\u3067$22.5M\u3092\u8abf\u9054","description":"\u30cb\u30e5\u30fc\u30b7\u30b0\u30ca\u30eb\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u306b\u3088\u308a\u30b7\u30ea\u30fc\u30baA\u306711.5\u5104\u5186\u306e\u8cc7\u91d1\u8abf\u9054\u3092\u884c\u3044\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/","og_locale":"ja_JP","og_type":"article","og_title":"Neusignal Therapeutics Raises $22.5M in Series A","og_description":"Neusignal Therapeutics has raised 1.15 billion yen in Series A funding through a third-party allotment of new shares.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/","og_site_name":"itbusinesstoday","article_published_time":"2025-02-06T13:30:14+00:00","article_modified_time":"2025-05-06T07:25:56+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Neusignal Therapeutics Raises $22.5 Million in Series A Funding","datePublished":"2025-02-06T13:30:14+00:00","dateModified":"2025-05-06T07:25:56+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/"},"wordCount":249,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp","keywords":["Alzheimer disease","Biotech","Investments","Neusignal Therapeutics","NTX","Series A funding"],"articleSection":["APAC","Biotech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/","name":"Neusignal Therapeutics\u304c\u30b7\u30ea\u30fc\u30baA\u3067$22.5M\u3092\u8abf\u9054","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp","datePublished":"2025-02-06T13:30:14+00:00","dateModified":"2025-05-06T07:25:56+00:00","description":"\u30cb\u30e5\u30fc\u30b7\u30b0\u30ca\u30eb\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7\u306b\u3088\u308a\u30b7\u30ea\u30fc\u30baA\u306711.5\u5104\u5186\u306e\u8cc7\u91d1\u8abf\u9054\u3092\u884c\u3044\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Neusignal-Therapeutics-Raises-_22.5-Million-in-Series-A-Funding.webp","width":1200,"height":800,"caption":"Neusignal-Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/neusignal-therapeutics-raises-22-5-million-in-series-a-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Neusignal Therapeutics Raises $22.5 Million in Series A Funding"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=5469"}],"version-history":[{"count":4,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5469\/revisions"}],"predecessor-version":[{"id":10701,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5469\/revisions\/10701"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/5470"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=5469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=5469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=5469"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=5469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}